The Biotech Growth Trust Plc Transaction in Own Shares
19 Enero 2024 - 11:08AM
UK Regulatory
TIDMBIOG
For immediate release
19 January 2024
THE BIOTECH GROWTH TRUST PLC
(the "Company")
MARKET PURCHASE OF COMPANY'S OWN SHARES
Notification is given, pursuant to the authority granted at Annual General
Meeting of the Company held on 27 July 2023 to make market purchases of the
Company's own shares up to an aggregate maximum of 5,583,329 that a market total
of 57,388 Ordinary shares of 25p each in the capital of the Company were
purchased today for cancellation by the Company at a price of 880.40 pence per
share.
Following this transaction and in conformity with the provisions of the
Transparency Directive, the Company hereby notifies the market that the total
number of Ordinary shares that the Company has in issue, less the total number
of Ordinary shares bought back for cancellation by the Company following such
purchase, and therefore, the total number of voting rights in the Company is
34,398,212. The Company does not currently hold any Ordinary shares in treasury.
The figure of 34,398,212 may be used by shareholders as the denominator for the
calculation by which they may determine if they are required to notify their
interest in, or change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
For and on behalf of
Frostrow Capital LLP
Company Secretary
For further information, please contact:
Mark Pope
Frostrow Capital LLP
Tel: 020 3 170 4913
This information was brought to you by Cision http://news.cision.com
END
(END) Dow Jones Newswires
January 19, 2024 12:08 ET (17:08 GMT)
Biotech Growth (LSE:BIOG)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Biotech Growth (LSE:BIOG)
Gráfica de Acción Histórica
De May 2023 a May 2024